BIO-UV Group (ALTUV) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
22 Jul, 2026Executive summary
Consolidated revenue for H1 2026 was €20.1M, nearly stable year-over-year compared to H1 2025.
Service & aftermarket segment grew strongly, while Solutions returned to growth after a prior decline.
Product division revenue declined due to commercial reorganization and inflationary pressures.
Major new project signed in aquaculture for a global salmon producer in Iceland.
Financial highlights
H1 2026 revenue: €20.1M, down 1% from H1 2025.
Service & aftermarket revenue: €7.5M, up 10% year-over-year.
Solutions revenue: €5.4M, up 4% year-over-year.
Product revenue: €7.2M, down 13% year-over-year.
Outlook and guidance
Full-year 2026 revenue target confirmed at €38M–€42M.
H2 2026 expected revenue: €18M–€22M, up from €15.5M in H2 2025.
Growth to be driven by Solutions (especially aquaculture export), normalized product sales, and continued service expansion.
Order book in mid-July 2026 slightly above prior year, with more export opportunities.
Latest events from BIO-UV Group
- Resilient margins and improved net profit amid revenue decline, with strong 2026 growth outlook.ALTUV
H2 202520 Apr 2026 - 2024 revenue fell 8% to €39.6M; export growth and capital increase to drive 2025 recovery.ALTUV
Trading Update28 Oct 2025 - EBITDA margin hit 13.5% with record free cash flow and major debt reduction, despite lower revenue.ALTUV
H2 202428 Oct 2025 - H1 2025 revenue down 8%, but services up 14% and organic growth targeted for 2025.ALTUV
Trading Update28 Oct 2025 - EBITDA margin improved to 17.3% and net income surged 258% despite lower revenue.ALTUV
H1 202528 Oct 2025 - Record free cash flow and improved margins offset lower revenue, with strong outlook for 2024.ALTUV
H1 202428 Oct 2025